A detailed history of Montecito Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, Montecito Bank & Trust holds 2,956 shares of NVS stock, worth $315,641. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,956
Previous 3,136 5.74%
Holding current value
$315,641
Previous $316,000 9.81%
% of portfolio
0.06%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$95.27 - $108.47 $17,148 - $19,524
-180 Reduced 5.74%
2,956 $285,000
Q4 2023

Jan 05, 2024

SELL
$92.27 - $101.54 $53,701 - $59,096
-582 Reduced 15.65%
3,136 $316,000
Q3 2023

Oct 16, 2023

SELL
$94.73 - $105.13 $1,042 - $1,156
-11 Reduced 0.29%
3,718 $378,000
Q2 2023

Jul 25, 2023

SELL
$92.52 - $104.91 $1,665 - $1,888
-18 Reduced 0.48%
3,729 $376,000
Q1 2023

Apr 24, 2023

SELL
$80.03 - $92.81 $41,295 - $47,889
-516 Reduced 12.1%
3,747 $344,000
Q4 2022

Jan 20, 2023

SELL
$75.55 - $92.52 $4,155 - $5,088
-55 Reduced 1.27%
4,263 $387,000
Q3 2022

Oct 14, 2022

SELL
$74.61 - $87.26 $5,222 - $6,108
-70 Reduced 1.6%
4,318 $328,000
Q2 2022

Aug 01, 2022

SELL
$80.52 - $93.75 $14,091 - $16,406
-175 Reduced 3.84%
4,388 $371,000
Q3 2021

Oct 28, 2021

SELL
$81.78 - $95.14 $7,360 - $8,562
-90 Reduced 1.93%
4,563 $373,000
Q2 2021

Jul 08, 2021

SELL
$85.24 - $94.15 $12,786 - $14,122
-150 Reduced 3.12%
4,653 $425,000
Q1 2021

Apr 26, 2021

SELL
$83.5 - $98.47 $29,225 - $34,464
-350 Reduced 6.79%
4,803 $410,000
Q2 2020

Jul 17, 2020

SELL
$80.93 - $91.1 $7,040 - $7,925
-87 Reduced 1.66%
5,153 $450,000
Q1 2020

Apr 23, 2020

BUY
$70.67 - $99.01 $2,614 - $3,663
37 Added 0.71%
5,240 $432,000
Q4 2019

Jan 22, 2020

BUY
$84.35 - $95.37 $40,572 - $45,872
481 Added 10.19%
5,203 $493,000
Q2 2019

Jul 05, 2019

BUY
$75.4 - $92.8 $54,740 - $67,372
726 Added 18.17%
4,722 $431,000
Q1 2019

Apr 05, 2019

BUY
$75.32 - $86.15 $300,978 - $344,255
3,996 New
3,996 $384,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Montecito Bank & Trust Portfolio

Follow Montecito Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montecito Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Montecito Bank & Trust with notifications on news.